Skip to main content
. 2013 May 31;9(8):1679–1684. doi: 10.4161/hv.24844

graphic file with name hvi-9-1679-g2.jpg

Figure 2. Study design. This paper will not present the data on subjects boosted at Year-5 for long-term persistence since number of subjects in this group were low (n = 2), and these results do not provide any clinically relevant information. N, number of subjects in the LT-ATP cohort; N*, number of subjects in the ATP cohort for the challenge phase.